Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G for BioCryst Pharmaceuticals, Inc. Common Stock, $0.01 par value per share (BCRX).
- Disclosed ownership: 7.3%.
- Date of event: 04 Nov 2025.
RA CAPITAL MANAGEMENT, L.P. - 04 Nov 2025 SCHEDULE 13G Report for BioCryst Pharmaceuticals, Inc. Common Stock, $0.01 par value per share (BCRX)
- Filing Manager
- RA CAPITAL MANAGEMENT, L.P.
- Reporting Manager
- RA Capital Management, L.P.
- Symbol
- BCRX
- Shares outstanding
- 209,618,986 shares
- Disclosed Ownership
- 15,302,186 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Nov 2025, 20:27:03 UTC
- Date of event
- 04 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 7.3% ownership in BioCryst Pharmaceuticals, Inc. Common Stock, $0.01 par value per share (BCRX) on 04 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Nov 2025, 20:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 7.3% | 15,302,186 | 0 | 15,302,186 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | |
| Peter Kolchinsky | 7.3% | 15,302,186 | 0 | 15,302,186 | /s/ Peter Kolchinsky | Peter Kolchinsky | |
| Rajeev Shah | 7.3% | 15,302,186 | 0 | 15,302,186 | /s/ Rajeev Shah | Rajeev Shah | |
| RA Capital Healthcare Fund, L.P. | 7.3% | 15,302,186 | 0 | 15,302,186 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager |